Liver TransplantationLiver DiseasesPhysiciansLiverMinnesotaAttitude of Health PersonnelLiver CirrhosisLiver NeoplasmsFamily PracticeHospitals, Group PracticeLiver FailureRetrospective StudiesLiver RegenerationGraft RejectionImmunosuppressive AgentsEnd Stage Liver DiseaseLiver Function TestsGraft SurvivalTreatment OutcomeFatty LiverMicrosomes, LiverTime FactorsLiving DonorsTacrolimusTissue DonorsKidney TransplantationPostoperative ComplicationsWaiting ListsTissue and Organ ProcurementDrug-Induced Liver InjuryFollow-Up StudiesRisk FactorsHepatectomyTransplantationMitochondria, LiverTransplantsLiver Failure, AcuteLiver CirculationAlanine TransaminaseCarcinoma, HepatocellularLiver Diseases, AlcoholicTransplantation, HomologousLiver Neoplasms, ExperimentalLiver ExtractsSurvival RateCyclosporineRecurrenceCohort StudiesSurvival AnalysisImmunosuppressionLiver Cirrhosis, AlcoholicMycophenolic AcidProspective StudiesPrognosisHepatic ArteryCadaverPortal VeinHepatocytesRisk AssessmentHepatitis COutpatient Clinics, HospitalHeart TransplantationIncidenceBiopsyReoperationPredictive Value of TestsCytomegalovirus InfectionsSeverity of Illness IndexLiver AbscessKaplan-Meier EstimateBilirubinArizonaBiliary AtresiaAge FactorsDonor SelectionTransplantation ImmunologyLiver Cirrhosis, ExperimentalPostoperative PeriodUnited StatesAntiviral AgentsCholestasisAspartate AminotransferasesMultivariate AnalysisQuestionnairesProportional Hazards ModelsBiliary Tract DiseasesHumeral HeadPatient SelectionCholangitis, SclerosingCase-Control StudiesPrimary DysautonomiasDisease ProgressionLiver GlycogenBiological MarkersAmbulatory Care FacilitiesFloridaLung TransplantationDrug Therapy, CombinationKidneyHepatitis